HomeCPRX • NASDAQ
add
Catalyst Pharmaceuticals Inc
Previous close
$16.00
Day range
$15.33 - $16.25
Year range
$11.09 - $17.78
Market cap
1.81B USD
Avg Volume
1.15M
P/E ratio
24.44
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 110.57M | 81.98% |
Operating expense | 51.10M | 248.34% |
Net income | 34.84M | 36.80% |
Net profit margin | 31.51 | -24.83% |
Earnings per share | 0.29 | 31.82% |
EBITDA | 50.84M | 61.81% |
Effective tax rate | 25.40% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 137.64M | -53.87% |
Total assets | 470.11M | 25.15% |
Total liabilities | 82.23M | 9.34% |
Total equity | 387.88M | — |
Shares outstanding | 117.86M | — |
Price to book | 4.42 | — |
Return on assets | 23.60% | — |
Return on capital | 28.03% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 34.84M | 36.80% |
Cash from operations | 55.65M | 38.85% |
Cash from investing | -38.32M | — |
Cash from financing | -665.00K | -129.52% |
Net change in cash | 16.66M | -60.63% |
Free cash flow | 8.73M | -73.15% |
About
Founded
2002
Headquarters
Website
Employees
167